Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome

Annals of the New York Academy of Sciences

Volumn 1092, Issue , 2006, Pages 138-147

  Valsamakis, George ^a,c   Kanaka Gantenbein, Christina ^b   Malamitsi Puchner, Ariadne ^a   Mastorakos, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Cardiovascular disease; Fetal origin; IUGR; Metabolic syndrome; SGA

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CYTOKINE;

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DISEASE COURSE; ENZYME ACTIVITY; FETUS DEVELOPMENT; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MALNUTRITION; MENTAL STRESS; METABOLIC SYNDROME X; MORTALITY; NEUROENDOCRINE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; FEMALE; HUMAN; PATHOPHYSIOLOGY; PREGNANCY; REVIEW;

FEMALE; FETAL GROWTH RETARDATION; HUMANS; METABOLIC SYNDROME X; PREGNANCY;

EID: 34247197104     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1365.012     Document Type: Conference Paper

References (49)

1. BARKER, D.J.P. 1998. Mothers, babies, and health in later life. Second edition. Barker, D.J.P., Ed.: Churchill Livingstone, New York.
2. PHILIPS, D.I.W. 2002. Endocrine programming and fetal origins of adult disease. Trends Endocrinol. Metab. 13: 363.
3. KANAKA-GANTENBEIN C, G. MASTORAKOS & G.P. CHROUSSOS. 2003. Endocrine related causes and consequences of intrauterine growth retardation. Ann. N. Y. Acad. Sci. 997: 150-157.
4. WOLLMANN, H.A. 1998. Intrauterine growth restriction: definition and etiology. Horm. Res. 49. (Suppl 2): 1-6.
5. LUCAS, A. 1991. Programming by early nutrition in man. The childhood environment and adult disease. In CIBA Foundation Symposium 156. John Wiley, Chinchester 38-55.
6. RAPPAPORT, R. 1993. Fetal growth in pediatric endocrinology: physiology, pathophysiology and clinical aspects. Second edition. J. Bertrand, R. Rappaport & P.C. Sizonenko, Eds.: Williams and Wilkins, Baltimore, MD.
7. BERNSTEIN, I. & S.G GABBE. 1996. Intrauterine growth restriction. In S.G. Gabbe, J.R. Niebyl, J.L. Simpson, G.L. Annas, et al., Eds.: 863-886. Obstetrics: normal and problem pregnancies. Third edition. Churchill Livingstone, New York.
8. NEERHOF, M.G. 1995. Causes of intrauterine growth restriction. Clin. Perinatol. 22: 375-385.
9. LEE, P.A., S.D. CHERNAUSEK, A.C. HOKKEN KOELEGA & P. CHERNICHOW. 2003. International Small for Gestational Age Advisory Board consensus development conference statement: management of small children born small for gestational age April 24-October 1, 2001. Paediatrics. 112: 180-182.
10. GARDOSI, J. 2006. New definition of small for gestational age based on fetal growth potential. Horm. Res. 65(Suppl 3): 15-18.
11. DESAI, M., N.J. CROWTHER, A. LUCAS & C.N. HALES. 1996. Organ-selective growth in the offspring of mothers protein-restricted. Br. J. Nutr. 76: 591-603.
12. BRYAN S.M. & P. HINDMARSH. 2006. Normal and abnormal fetal growth. Horm. Res. 65 (Suppl 3): 19-27.
13. SZITANYI, P., J. JANDA & R. POLDENE. 2003. Intrauterine undernutrition and programming as a new risk of cardiovascular disease in later life. Physiol. Res. 52: 389-395.
14. GARROW, J.S., K. FLETCHER & D. HALLIDAY. 1965. Body composition in severe infantile malnutrition. J. Clin. Invest. 44: 417-425.
15. SYMONDS, M.E., S. PEARCE, J BISPHAM, et al. 2004. Timing of nutrient restriction and programming of fetal adipose tissue. Proceedings of the Nutrition Society. 63: 397-403.
16. FERNANDEZ-TWINN D.S., S.E. OZANNE & S. EKIZOGLOU. 2003. The maternal endocrine environment in the low protein model of intrauterine growth restriction. Br. J. Nutr. 90: 815-822.
17. OZANNE, S.E., G.S. OLSEN & L.L. HANSEN. 2003. Early growth restriction leads to down regulation of protein kinase zeta and insulin resistance in skeletal muscle. J. Endocrinol. 177: 235-241.
18. ZHANG, X., J.H. SLIWOWSKA & J. WEINBERG. 2005. Prenatal alcohol exposure and fetal programming: effects on neuroendocrine and immune function. Exp. Biol. Med. 230: 376-388.
19. OZANNE, S.E. & N. HALES. 2002. Early programming of glucose insulin metabolism. Trends Endocrinol. Metab. 13: 368-373.
20. GLAZIER, J.D., I. CETIN, G. PERUGINO, et al. 1997. Association between the activity of the system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Paediatr. Res. 42: 514-519.
21. MC INTYRE H.D., R. SEREK, D.I. CRANE, et al. 2000. Placental growth hormone, GH-binding, and insulin like growth factor axis in normal, growth retarded and diabetic pregnancies: correlations with fetal growth. J. Clin. Endocrinol. Metab. 85: 1143-1150.
22. SHAMS, M., M.D. KILBY & D.A SOMERSET. 1998. 11beta-hydroxysteroid dehydrogenase type 2 activity in human pregnancy and reduced expression in intrauterine growth restriction. Hum. Reprod. 13: 799-804.
23. MCTERNAN, C.L., N. DRAPER, H. NICHOLSON, et al. 2001. Reduced placental 11β- hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J. Clin. Endocrinol. Metab. 86: 4979-4983.
24. WEINSTOCK, M. 2005. The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav. Immun. 19: 296-308.
25. WADHWA, P.D., C DUNKEL-SCHETTER, A. CHIEZ-DEMET, et al. 1996. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom. Med. 58: 432-446.
26. CHALLIS, J.R.C. 2000. Endocrine and paracrine regulation of birth at term and preterm. Endocr. Rev. 21: 514-550.
27. GLUCKMAN, P.D. & J.E HARDING. 1997. The physiology and pathophysiology of intrauterine growth retardation. Horm. Res. 48: 11-16.
28. GICQUEL, C. & Y. LE BOUC. 2006. Hormonal regulation of fetal growth. Horm. Res. 65(Suppl 3): 28-33.
29. GLUCKMAN, P.D. 1997. Endocrine and nutritional regulation of prenatal growth. Acta Paediatr. 423: 153-157.
30. WOODS, K.A., C. CAMACHO-HUBNER, M.O. SAVAGE & A. CLARK. 1996. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor-1 gene. N. Engl. J. Med. 335: 1363-1367.
31. CUTFIELD, W.S., P.L. HOFMAN, M. VICKERS, et al. 2002. IGFs and binding proteins in short children with intrauterine growth retardation. J. Clin. Endocrinol. Metab. 87: 235-239.
32. NIETO-DIAZ A, J. VILLAR, R MATORRAS-WEINIG & P VALENZUELA-RUIZ. 1996. Intrauterine growth retardation at term: association between antropometric and endocrine parameters. Acta Obstet. Gynecol. Scand. 75: 127-131.
33. WARD, A.M., H.E. SYDDALL, P.J. WOOD, et al. 2004. Fetal programming of the hypothalamic-pituitary-adrenal axis: low birth weight and cer HPA regulation. J. Clin. Endocrinol. Metab. 89: 1227-1233.
34. LAPPAS, M., M. PERMEZEL & G.E. RICE. 2004. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 89: 5627-5633.
35. MYATT, L., W. KOSSENJANS, R SAHAY, et al. 2000. Oxidative stress causes vascular dysfunction in the placenta. J. Maternal Fetal Neonatal Med. 9: 79-82.
36. ABRAMOV, Y., Y. EZRA, U. ELCHALAL, et al. 2004. Markedly elevated levels of inflammatory cytokines in maternal serum and peritoneal washing during arrested labor. Acta Obstet. Scand. 83: 358-363.
37. KOTANI, Y., I. YOKOTA, S. KITAMURA, et al. 2004. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin. Endocrinol. 61: 418-423.
38. BARKER D.J.P., P.D. GLUCKMAN, K.M. GODFREY, et al. 1993. Fetal nutrition and cardiovascular disease. Lancet 341: 938-941.
39. BARKER D.J.P., C.N. HALES, C.H. FALL, et al. 1993. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62-67.
40. JAQUET, D., J. LEGER, P. CSERNICHOW & C LEVY-MARCHAL. 2002. The effect of in utero undernutrition on the insulin resistance syndrome. Curr. Diab. Rep. 2: 77-82.
41. HOFMAN, P.L., W.S. CUTFIELD, E.M. ROBINSON, et al. 1997. Insulin resistance in short children with intrauterine growth retardation. J. Clin. Endocrinol. Metab. 82: 402-406.
42. YAZNIK, C.S. 2004. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J. Nutr. 134: 205-210.
43. OZANNE, S.E., C.B. JENSSEN, K.J. TINGEY, et al. 2005. Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 48: 547-552.
44. CIANFARANNI, S., C. MARTINEZ, A. MAIORANA, et al. 2004. Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal growth catch-up. J. Clin. Endocrinol. Metab. 89: 1346-1351.
45. FRANKEL, S., P. ELWOOD, P. SWEETNAM, et al. 1996. Birthweight, body mass index in middle age and incident coronary heart disease. Lancet 348: 1478-1480.
46. JIANG, B., K.M. GODFREY, C.N. MARTYN & C.R. GALE. 2006. Birth weight and cardiac structure in children. Paediatrics 117: 257-261.
47. BARKER D.J.P., T. FORSEN, J.E. ERIKSSON & C. OSMOND. 2002. Growth and living conditions in childhood and hypertension in adult life: longitudinal study. J. Hypertension 20: 1951-1956.
48. JONES, A., K.M. GODFREY, P. WOOD, et al. 2006. Fetal growth and the adrenocortical response to psychological stress. J. Clin. Endocrinol. Metab. 91(5): 1868-1871.
49. LEIBSON, C.L., J.P. BURKE, B.S. RANSOM, et al. 2005. Relative risk of mortality associated with diabetes as a function of birthweight. Diab. Care 28: 2839-2845.